Clinical trial

Enhancement by Poly-ICLC During HIV-1 Infection

NCT02071095

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2014-04-01Date precision: month

Registry last updated2018-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1 Infected Adults With Chronic HIV-1 Infectionunresolved

Interventions

Arm A: Poly-ICLCDRUG

Arm B: Normal SalineDRUG

Sponsors & collaborators

Nina Bhardwajlead sponsor

The Campbell Foundationcollaborator

Oncovir, Inc.collaborator

National Institutes of Health (NIH)collaborator

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02071095 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.